3,131
Views
0
CrossRef citations to date
0
Altmetric
Review

DNA methylation episignatures: insight into copy number variation

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1373-1388 | Received 17 Aug 2022, Accepted 23 Nov 2022, Published online: 20 Dec 2022
 

Abstract

In this review we discuss epigenetic disorders that result from aberrations in genes linked to epigenetic regulation. We describe current testing methods for the detection of copy number variants (CNVs) in Mendelian disorders, dosage sensitivity, reciprocal phenotypes and the challenges of test selection and overlapping clinical features in genetic diagnosis. We discuss aberrations of DNA methylation and propose a role for episignatures as a novel clinical testing method in CNV disorders. Finally, we postulate that episignature mapping in CNV disorders may provide novel insights into the molecular mechanisms of disease and unlock key findings of the genome-wide impact on disease gene networks.

Author contributions

L van der Laan, K Rooney, MMAM Mannens, P Henneman and B Sadikovic contributed to the initial study conception and design. L van der Laan, K Rooney and TMA Trooster designed the figures and tables. The manuscript was written by L van der Laan and K Rooney, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Financial & competing interests disclosure

The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.

No writing assistance was utilized in the production of this manuscript.